Breztri Aerosphere

Breztri Aerosphere® is a prescription inhaler used for the long-term maintenance treatment of COPD (chronic obstructive pulmonary disease). It’s designed to help keep airways open and reduce inflammation over time - but it’s not for asthma and not for sudden breathing attacks. Think of it as part of your daily routine to manage symptoms, not something you grab in an emergency.

• Contains 3 medicines in one inhaler (ICS + LAMA + LABA)
• Helps reduce inflammation and relax airway muscles
• Used regularly to manage COPD symptoms over time
• Not a rescue inhaler for sudden shortness of breath
• Prescription-only treatment that requires provider evaluation

Breztri Aerosphere® is used as a scheduled daily inhaler, not on-demand. You inhale the medication through your mouth, typically twice a day, to help keep your breathing stable over time. It’s important to use it consistently - even if you’re feeling okay - since it works in the background to support your lungs.

• Taken as an inhalation (metered-dose inhaler / MDI)
• Usually used morning and evening (as prescribed)
• Not meant for quick relief during breathing emergencies
• Rinse your mouth after use to help prevent irritation
• Do not take extra doses unless your provider tells you

Like all medications, Breztri Aerosphere® can cause side effects. Many people tolerate it well, but some may notice mild symptoms, especially when starting. There are also a few important warning signs to watch for that may need medical attention.

• Common: cough, sore throat, upper respiratory infections
• Possible: oral thrush (white patches in mouth), headache, muscle spasms
• May increase risk of infections like pneumonia
• Get medical help right away if breathing suddenly worsens after use
• Contact a provider or take emergency care if you notice signs of allergic reaction (rash, swelling, trouble breathing)

For more detail refer to the Important Safety / Prescribing Information.

No - Breztri is not designed for sudden breathing problems or asthma attacks. It works as a maintenance inhaler for COPD, meaning it helps over time when used regularly, not instantly.

• It does not act fast enough for emergency relief
• Using it during an attack may delay proper treatment
• You should use a rescue inhaler for sudden symptoms

If you experience a sudden worsening of breathing, use your prescribed rescue medication and seek medical help if symptoms don’t improve. Always follow your provider’s emergency plan.

Breztri is not approved for asthma treatment. It is specifically indicated for COPD, and using it for asthma would be outside its approved use.

• Your provider will choose a treatment based on your diagnosis
• Asthma and COPD require different treatment approaches
• Using the wrong inhaler may not control symptoms effectively

If you’re unsure about your diagnosis or current treatment, it’s best to speak with a healthcare provider before starting or switching medications.

If you miss a dose, take it as soon as you remember - unless it’s close to your next scheduled dose. In that case, skip the missed dose and continue your regular schedule.

• Do not take two doses at once
• Stay consistent with your daily routine
• Set reminders if needed to avoid missed doses

Missing an occasional dose may happen, but regular use is important for long-term control. If you miss doses often, talk to your provider about ways to stay on track.

No - you should not take extra doses unless your provider tells you to. Breztri is not meant for quick symptom relief, and taking more than prescribed may increase the risk of side effects.

• It won’t provide fast relief during sudden symptoms
• Overuse may affect your heart or other systems
• Use a rescue inhaler for immediate breathing issues

If you’re often feeling short of breath, your treatment plan may need adjustment.

Yes - rinsing your mouth after each use is recommended. This helps reduce the risk of developing oral thrush, a fungal infection that can occur with inhaled corticosteroids.

• Rinse with water and spit it out (do not swallow)
• Helps keep your mouth and throat healthy
• Quick step that can prevent irritation

If you notice white patches, soreness, or discomfort in your mouth, let your provider know.

Yes - these two inhalers serve different purposes and are often used together as part of a treatment plan.

• Breztri is for daily maintenance
• Rescue inhalers are for sudden symptoms
• Always keep your rescue inhaler nearby

Make sure your provider knows all the inhalers you’re using to avoid overlap or interactions. If you’re using your rescue inhaler frequently, it may be a sign your condition needs reassessment.

There’s no direct restriction on alcohol in the prescribing information, but it’s still a good idea to be cautious. Alcohol can affect your overall health and may interact with certain conditions or medications.

• Monitor how your body responds
• Avoid excess alcohol if you have underlying conditions
• Check with your provider if unsure

If you notice unusual symptoms after drinking, or if you take other medications, it’s best to get personalized advice.

Most people can continue normal activities like driving, but it depends on how you personally react to the medication.

• Be aware of symptoms like dizziness or palpitations
• Avoid driving if you feel unwell after use
• Give yourself time to understand how your body responds

If you experience side effects that affect focus or coordination, speak with your provider before continuing to drive.

Store your inhaler in a cool, dry place at room temperature. Because it’s a pressurized canister, it should be handled with care.

• Keep away from heat, flames, and direct sunlight
• Do not store in very hot environments (like cars)
• Keep it in its original packaging until use

When traveling, avoid exposing it to extreme temperatures. Proper storage helps ensure the medication works as intended.

You should discard your inhaler based on the dose counter or the expiration timeline after opening, whichever comes first.

• Do not use it once the counter reaches zero
• Follow the discard date listed on the packaging
• Even if it feels like there’s medication left, it may not deliver a full dose

Yes, especially if you’re using other inhalers with similar ingredients. Some combinations may increase the risk of side effects.

• Avoid using multiple LABA or anticholinergic inhalers together unless prescribed
• Always share your full medication list with your provider
• Do not add or switch inhalers without guidance

Your provider will help you build a safe and effective treatment plan.

Some symptoms need immediate attention. While not common, it’s important to recognize warning signs early.

• Sudden worsening of breathing after use
• Signs of allergic reaction (swelling, rash, trouble breathing)
• Chest pain or irregular heartbeat
• Signs of infection like fever or persistent cough

If you’re unsure whether a symptom is serious, it’s always safer to check with a healthcare provider.

You should not stop using Breztri without speaking to your provider. Even if you feel better, the medication is working in the background to keep symptoms controlled.

• Stopping suddenly may lead to worsening symptoms
• Treatment plans are designed for long-term use
• Your provider can guide any changes safely

If you’re thinking about stopping or switching treatments, discuss it first to avoid unnecessary risks.

Yes - Breztri is a prescription-only medication. A licensed healthcare provider must evaluate your condition before it can be prescribed.

• Requires medical review (online or in-person)
• Prescription ensures safe and appropriate use

US Quick Health can make this process more convenient, but a clinical decision is always required.

Breztri Aerosphere® (Budesonide/Glycopyrrolate/Formoterol 160/9/4.8 mcg) - triple therapy inhaler (ICS + LAMA + LABA) used for maintenance treatment of COPD, combining anti-inflammatory, bronchodilator, and anticholinergic effects. / Source: NCBI

Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71a5433dc-cb2b-43ea-b6df-c5b4177adc6c / Published: July 23, 2020